How Expectations for Q2 2026 Earnings Could Shape MakeMyTrip (MMYT) Growth Narrative

• MakeMyTrip Limited recently announced that it will report its fiscal 2026 second quarter financial and operating results before markets open on October 28, 2025, with a live management discussion and replay available through its Investor Relations website.
• Investor attention is centering on MakeMyTrip due to analyst projections of significant year-over-year growth in both earnings per share and revenue for the upcoming quarter.
• We'll explore how strong expectations for MakeMyTrip's quarterly earnings could influence assumptions around its future growth trajectory and valuation.

The end of cancer? These 28 emerging AI stocks are developing tech that will allow early identification of life changing diseases like cancer and Alzheimer's.

MakeMyTrip Investment Narrative Recap

To be a MakeMyTrip shareholder today, an investor needs confidence in India's expanding digital travel market, the platform’s user engagement and adoption, and ongoing digitalization in tier-2 and tier-3 cities. The upcoming Q2 2026 results, with analyst expectations for strong EPS and revenue growth, remain the leading short-term catalyst. The material risk remains that heavy customer acquisition costs and high competition in the online travel sector could still limit margin progression; the recent news does not fundamentally alter that equation in the near term.

Among recent developments, the launch of MakeMyTrip’s GenAI-enabled Trip Planning Assistant stands out, as it enhances the customer experience across languages and booking platforms. This innovation aligns directly with the growth catalyst of product improvements designed to increase user retention and conversion, supporting arguments for both near-term earnings growth and a longer pathway for margin expansion.

Yet, despite these advances, aggressive pricing moves by competitors could pressure MakeMyTrip’s revenue and margin outlook if...

Read the full narrative on MakeMyTrip (it's free!)

MakeMyTrip's outlook anticipates $1.8 billion in revenue and $288.3 million in earnings by 2028. This reflects a required annual revenue growth rate of 22.2% and a $188.3 million increase in earnings from the current $100 million.

Uncover how MakeMyTrip's forecasts yield a $121.00 fair value, a 36% upside to its current price.

Exploring Other Perspectives

Fair value estimates from three Simply Wall St Community members span from US$26.07 to over US$180,922.76 per share, capturing a vast spectrum of expectations. With competition and high customer acquisition costs still weighing on margins, you can see just how widely market participants’ opinions can differ, explore a range of perspectives to broaden your understanding.

Explore 3 other fair value estimates on MakeMyTrip - why the stock might be worth less than half the current price!

Build Your Own MakeMyTrip Narrative

Disagree with existing narratives? Create your own in under 3 minutes - extraordinary investment returns rarely come from following the herd.

• A great starting point for your MakeMyTrip research is our analysis highlighting 2 key rewards and 2 important warning signs that could impact your investment decision.
• Our free MakeMyTrip research report provides a comprehensive fundamental analysis summarized in a single visual - the Snowflake - making it easy to evaluate MakeMyTrip's overall financial health at a glance.

Ready To Venture Into Other Investment Styles?

Our top stock finds are flying under the radar-for now. Get in early:

• AI is about to change healthcare. These 33 stocks are working on everything from early diagnostics to drug discovery. The best part - they are all under $10b in market cap - there's still time to get in early.
• Trump has pledged to "unleash" American oil and gas and these 22 US stocks have developments that are poised to benefit.
• The latest GPUs need a type of rare earth metal called Neodymium and there are only 36 companies in the world exploring or producing it. Find the list for free.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com